WallStSmart

Accenture plc (ACN)vsIBEX Ltd (IBEX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 11853% more annual revenue ($72.11B vs $603.27M). ACN leads profitability with a 10.6% profit margin vs 7.3%. IBEX trades at a lower P/E of 9.3x. IBEX earns a higher WallStSmart Score of 63/100 (C+).

ACN

Buy

60

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 7.3Quality: 5.3
Piotroski: 3/9Altman Z: 2.79

IBEX

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 7.0Value: 8.3Quality: 8.0
Piotroski: 5/9Altman Z: 3.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNSignificantly Overvalued (-19.5%)

Margin of Safety

-19.5%

Fair Value

$160.91

Current Price

$192.29

$31.38 premium

UndervaluedFair: $160.91Overvalued
IBEXUndervalued (+78.6%)

Margin of Safety

+78.6%

Fair Value

$140.87

Current Price

$26.79

$114.08 discount

UndervaluedFair: $140.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN4 strengths · Avg: 8.5/10
Market CapQuality
$118.34B9/10

Large-cap with strong market position

Return on EquityProfitability
24.8%9/10

Every $100 of equity generates 25 in profit

P/E RatioValuation
15.8x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$3.67B8/10

Generating 3.7B in free cash flow

IBEX6 strengths · Avg: 9.0/10
P/E RatioValuation
9.3x10/10

Attractively priced relative to earnings

Return on EquityProfitability
33.7%10/10

Every $100 of equity generates 34 in profit

Altman Z-ScoreHealth
3.6210/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
16.7%8/10

16.7% revenue growth

EPS GrowthGrowth
45.6%8/10

Earnings expanding 45.6% YoY

Areas to Watch

ACN3 concerns · Avg: 3.7/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

IBEX3 concerns · Avg: 2.7/10
Market CapQuality
$377.22M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.3%3/10

7.3% margin — thin

Free Cash FlowQuality
$-5.09M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, P/E Ratio.

Bull Case : IBEX

The strongest argument for IBEX centers on P/E Ratio, Return on Equity, Altman Z-Score. Revenue growth of 16.7% demonstrates continued momentum.

Bear Case : ACN

The primary concerns for ACN are PEG Ratio, EPS Growth, Piotroski F-Score.

Bear Case : IBEX

The primary concerns for IBEX are Market Cap, Profit Margin, Free Cash Flow.

Key Dynamics to Monitor

ACN profiles as a value stock while IBEX is a growth play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.25 — expect wider price swings.

IBEX is growing revenue faster at 16.7% — sustainability is the question.

ACN generates stronger free cash flow (3.7B), providing more financial flexibility.

Bottom Line

IBEX scores higher overall (63/100 vs 60/100) and 16.7% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

IBEX Ltd

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

IBEX Limited provides comprehensive technology-enabled customer lifecycle experience solutions in the United States and internationally.

Visit Website →

Want to dig deeper into these stocks?